Page last updated: 2024-12-11

kaempferol 3-o-neohesperidoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

kaempferol 3-O-neohesperidoside: isolated from Daphniphyllum calycinum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
DaphniphyllumgenusBroad-leaved evergreen shrub or small tree comprising several species. It is the only genus of the family DAPHNIPHYLLACEAE, class MAGNOLIOPSIDA.[MeSH]DaphniphyllaceaeVascular plants of the order SAXIFRAGALES, class MAGNOLIOPSIDA, of which the sole genus is DAPHNIPHYLLUM.[MeSH]

Cross-References

ID SourceID
PubMed CID5318761
CHEMBL ID442988
CHEBI ID185334
MeSH IDM0291395

Synonyms (22)

Synonym
CHEMBL442988
kaempferol 3-o-neohesperidoside
kaempferol 3-neohesperidoside
CHEBI:185334
3-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
S3278
S5468
32602-81-6
40437-72-7
kaempferol-3-o-glucorhamnoside
AKOS037514501
HY-107207
Q63398320
CS-0027642
CCG-270175
3-(((2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)tetrahydro-2h-pyran-2-yl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-chromen-4-one
MS-30567
kaempferol-3-o-neohesperidoside
kaempferol-3-o-glucorhamnoside - 65%
XK175847
XK175326
DTXSID201304657
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
flavonoidsAny organic molecular entity whose stucture is based on derivatives of a phenyl-substituted 1-phenylpropane possessing a C15 or C16 skeleton, or such a structure which is condensed with a C6-C3 lignan precursors. The term is a 'superclass' comprising all members of the classes of flavonoid, isoflavonoid, neoflavonoid, chalcones, dihydrochalcones, aurones, pterocarpan, coumestans, rotenoid, flavonolignan, homoflavonoid and flavonoid oligomers. Originally restricted to natural products, the term is also applied to synthetic compounds related to them.
glycosideA glycosyl compound resulting from the attachment of a glycosyl group to a non-acyl group RO-, RS-, RSe-, etc. The bond between the glycosyl group and the non-acyl group is called a glycosidic bond. By extension, the terms N-glycosides and C-glycosides are used as class names for glycosylamines and for compounds having a glycosyl group attached to a hydrocarbyl group respectively. These terms are misnomers and should not be used. The preferred terms are glycosylamines and C-glycosyl compounds, respectively.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID1617255Cytotoxicity against nutrient-rich DMEM cultured human PANC1 cells at PC50 incubated for 24 hrs by WST-8 assay
AID1446625Cytotoxicity against human A549 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1446622Cytotoxicity against mouse BV2 cells assessed as cell viability at 20 uM after 24 hrs by MTT assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1446628Cytotoxicity against human BT549 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1446624Cytotoxicity against rat C6 cells assessed as cell viability at 20 uM after 24 hrs by MTT assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1446626Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1617250Anti-austerity activity against nutrient-deprived human PANC1 cells assessed as cell death incubated for 24 hrs by WST-8 assay
AID1446627Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1446623Neuroprotective activity in rat C6 cells assessed as NGF secretion at 20 uM after 24 hrs by ELISA relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1446621Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitrite production after 24 hrs by Griess assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.23 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]